Guardian Pharmacy Services, Inc.

NYSE:GRDN

Medical - Distribution

Healthcare
$48.84 +0.39%

+$0.17 today

Market cap
$3.09B
Beta
0.08
P/E (TTM)
52.0
EPS (TTM)
$0.84
52W Low $19.30High $44.00

Volume 0.45M

Average 0.48M

GRDN Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Guardian Pharmacy Services, Inc.NYSE: GRDN

Weighted Avg Shares (Diluted) · Q2 FY2026 · quarter ended Jun 2026

Weighted avg shares (diluted) grows in line with its trailing trend

Q2 FY2026 weighted avg shares (diluted) of 63.84M shares rose 1.0% year over year, behind the +2.5% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 0.2% from the prior quarter. Over 3 fiscal years it compounded at +1.3% a year.

Context

  • Weighted avg shares (diluted) increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +1.0% toward the trailing-twelve-month pace of +2.5%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
63.84M+0.2% QoQ
Last fiscal yearDec 2025
63.3M+2.1% YoY
LTMJun 2026
63.64M+2.5% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+1.0%——
1 year+2.1%——
3-year CAGR+1.3%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
63.3M USD
Year-over-year change
+2.1%
4-year CAGR
+1.0%

Weighted Avg Shares (Diluted) vs competitors

How GRDN compares with its peers on the latest reported figures

  • GRDN's LTM Jun 2026 weighted avg shares (diluted) of 63.64M shares is the 7th highest of the 11 companies compared; the peer median is 73.68M shares.
  • Its year-over-year change of +2.5% is the 7th highest of 11, against a peer median of +3.8%.
  • Over three fiscal years its annual growth of +1.3% compares with a peer median of +6.7%.
GRDN Competitors Peer median
Weighted Avg Shares (Diluted) for GRDN and competitors
Company Period LTM YoY 3-year CAGR
NUVBNuvation Bio Inc.LTM Jun 2026353.26M +9.5%+16.4%
MESOMesoblast LimitedLTM Jun 2026129.49M +7.2%+15.6%
TXG10x Genomics, Inc.LTM Sep 2026129.04M +4.4%+3.1%
MDPediatrix Medical Group, Inc.LTM Sep 202682.16M -4.5%+0.5%
EWTXEdgewise Therapeutics, Inc.LTM Sep 202679.43M -20.2%+24.3%
QDELQuidelOrtho CorporationLTM Mar 202667.93M +1.0%+5.7%
GRDNGuardian Pharmacy Services, Inc.LTM Jun 202663.64M +2.5%+1.3%
JANXJanux Therapeutics, Inc.LTM Mar 202662.14M +9.2%+14.3%
TWSTTwist Bioscience CorporationLTM Sep 202661.95M +3.1%+3.3%
PRCTPROCEPT BioRobotics CorporationLTM Mar 202655.94M +5.4%+7.8%
NHCNational HealthCare CorporationLTM Sep 202615.81M +1.2%+0.4%
Peer median (excluding GRDN) 73.68M+3.8%+6.7%

Competitors are the stored peer set for GRDN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue792.07M908.91M1.05B1.23B1.45B
Cost of Revenue630.81M723.04M837.88M984.04M1.17B
Gross Profit161.27M185.87M208.31M244.37M282.04M
Gross Margin20.4%20.4%19.9%19.9%19.5%
Research & Development00000
Selling, General & Admin131.12M133.88M167.36M307.29M193.13M
Operating Expenses131.12M133.88M167.36M307.29M193.13M
Depreciation & Amortization16.53M16.56M18.23M19.77M22.34M
EBITDA46.49M68.15M58.81M(43.43M)96.42M
EBITDA Margin5.9%7.5%5.6%-3.5%6.7%
Operating Income30.15M51.99M40.95M(62.92M)88.91M
Operating Margin3.8%5.7%3.9%-5.1%6.1%
Interest Income00000
Interest Expense1.64M1.93M2.86M3.28M665K
Other Income / Expenses(1.82M)(2.33M)(3.23M)(3.56M)(15.49M)
Income Before Tax28.33M49.66M37.72M(66.48M)73.42M
Pre-Tax Margin3.6%5.5%3.6%-5.4%5.1%
Income Tax Expense0004.56M24.47M
Net Income16.31M35.42M23.9M(87.29M)49.22M
Net Margin2.1%3.9%2.3%-7.1%3.4%
EPS (Basic)0.270.580.39(1.77)0.79
EPS (Diluted)0.270.580.39(1.77)0.78
Weighted Avg Shares60.84M60.84M60.84M62.01M62.39M
Weighted Avg Shares (Diluted)60.84M60.84M60.84M62.01M63.3M

Guardian Pharmacy Services, Inc.

NYSE:GRDN

Intrinsic Alpha fair value

Locked

Current Price

$48.84

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.